Armata Pharmaceuticals, Inc.

ARMP · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$27-$16-$7$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$0
Change in WC$2-$2-$1$1
Other Non-Cash$20$10-$1-$12
Operating Cash Flow-$4-$7-$8-$8
Investing Activities
PP&E Inv.-$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0$0
Financing Activities
Debt Repay.$15$0$10-$35
Stock Issued$0$0$0$0
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0$35
Financing Cash Flow$15$0$10$0
Forex Effect$0$0$0$0
Net Chg. in Cash$10-$7$2-$8
Supplemental Information
Beg. Cash$4$17$15$23
End Cash$15$10$17$15
Free Cash Flow-$5-$7-$8-$8
Armata Pharmaceuticals, Inc. (ARMP) Financial Statements & Key Stats | AlphaPilot